POSITIVE RECOMMENDATION BY COMMITTEE FOR ADVANCED THERAPIES CONFIRMS QUALITY OF THE MANUFACTURING PROCESS AND PRECLINICAL DATA SUBMITTED Mendus AB , a biopharmaceutical company focused on. | June 19, 2023
The board of directors of Mendus AB , reg. no 556629-1786, complete proposal for resolution on approval of directed issue of shares and warrants . | June 9, 2023
The board of directors of Mendus AB , reg. no 556629-1786, complete proposal for resolution on approval of issue of shares and warrants with preferential rights for existing. | June 9, 2023
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a. | June 8, 2023